SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as the community discusses recent developments including Gravity SUV deliveries in Canada and a partnership with Riyadh Season. Despite positive news, concerns persist around production targets, potential dilution, and the company's overall financial health, fueling debate among investors. Some are optimistic about Lucid's technology and long-term potential, while others express skepticism about its ability to compete effectively in the EV market.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine ($APPS) is trending as investors discuss its potential in the evolving app store landscape following recent rulings and potential AI partnerships; the community is actively debating whether the stock's current momentum is sustainable and if it can maintain its upward trajectory, with some closely watching for a breakout while short positions may get squeezed. Broader discussions cover the company's restructuring, potential acquisitions, and impact of broader market trends.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending as the quantum computing sector gains momentum, with community members highlighting its undervaluation compared to peers like $RGTI and potential links to $NVDA. Discussions revolve around the upcoming merger with Infleqtion and its participation in the Q+AI Conference 2025 as potential catalysts. Some investors express excitement about the stock's long-term potential, drawing parallels to past SPAC successes.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending due to positive sentiment around potential upgrades and community excitement about its gains, with some eyeing a move to double digits. Bullish traders are celebrating recent wins and expressing confidence in the stock's undervaluation, citing Wedbush's price target. However, some caution exists regarding potential pullbacks, with a few traders closing positions for profit.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending due to a mix of factors, including recent price volatility and discussions around a potential CEO share sale. The community is debating potential support levels and whether the stock is currently oversold, while also considering the company's broader positioning in the telehealth and pharmaceutical landscape.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences N.V.

ATAI is trending after receiving FDA Breakthrough Therapy Designation for its depression treatment, BPL-003, driving excitement among investors. Community members are discussing Jefferies' raised price target to $10 and the potential for Phase 3 trials, while also weighing the impact of a recent public offering.  The stock is viewed by some as a long-term play in the burgeoning psychedelic medicine sector, drawing comparisons to $TSLA and $NVDA.

Firecoin is a digital asset inspired by the concept of the eternal flame, representing energy, resilience, and guidance. It is designed to act as a decentralized token that embodies light and strength, giving holders a sense of empowerment in the digital economy. The project’s purpose is to create a community-driven ecosystem where Firecoin symbolizes progress, illumination, and the ability to move forward regardless of challenges. By leveraging blockchain technology, Firecoin aims to provide transparency, security, and accessibility to its users while maintaining its thematic connection to the symbolic power of fire.

firecoin

$FIRECOIN is trending due to increasing attention within the Phantom Wallet community, with many users highlighting its potential for significant gains. The community is actively discussing its availability on Phantom Wallet and anticipating a potential 'moonshot,' while some users are raising concerns about potential scams.

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Mind Medicine Inc

Mind Medicine Inc - Ordinary Shares (Sub Voting)

MNMD is trending as the community discusses potential catalysts, including positive trial data and regulatory developments in the psychedelics sector.  Bullish sentiment is fueled by the anticipation of significant price appreciation and potential buyouts, with the company's strong cash position and ongoing Phase 3 trials cited as key factors. Discussions also involve the broader context of psychedelic medicine's growing acceptance and potential to revolutionize mental health treatment.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on September 3, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings is trending due to upcoming live-fire trials in the UAE and discussions for strategic opportunities in Indian defense modernization programs, generating excitement around potential contracts. Community members are closely watching key resistance levels, particularly a break above $12.50, and discussing the warrants, viewing the company as undervalued in the AI and defense sector.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending due to a mixed reaction to its AI World event and announcements, including a partnership with Meta and ambitious long-term revenue targets. While some analysts are optimistic, concerns linger in the community about near-term profitability, heavy AI capex, and execution risks. Community members are actively discussing potential price movements, upgrades from analysts, and the impact of AI deals on Oracle's future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot...

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Dr. Mimi Lee, MD, PhD, as Chief Precision Medicine Officer. Dr. Lee will spearhead...

InnovAge (INNV) Surges 8.6%: Is This an Indication of Further Gains?

InnovAge (INNV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

GeneDx to Partner with Floridas Sunshine Genetics Network, Launching Nations First State-Backed Genomic Newborn Screening Program

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Florida State University has selected GeneDx as one of its partners for the recently...

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the Autism Partnership Program to expand access to its industry leading exome and...

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 

GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.

Here's Why Ensign Group Shares Are Attracting Investors Now

ENSG stock is surging on revenue growth, acquisitions and raised 2025 earnings and sales guidance.

Here's Why Pediatrix Medical Shares Are Attracting Investors Now

MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.

PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down

Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.

Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

WGS
GeneDx Holdings Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest WGS News

WGSGeneDx Holdings Corp